Product information
From Health Canada
Current status:
Approved
Current status date:
2021-01-18
Product name:
TERAZOSIN
DIN:
02233049 Electronic product monograph is not available
Company:
APOTEX INC
150 Signet Drive
Toronto
Ontario
Canada
M9L 1T9
Class:
Human
Dosage form(s):
Tablet
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
24:20.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
G04CA03 TERAZOSIN
Active ingredient group (AIG) number:See footnote5
0136978003
Active ingredient(s) | Strength |
---|---|
TERAZOSIN (TERAZOSIN HYDROCHLORIDE) | 5 MG |